Sharemaestro Newsreel

Signaturefd LLC Buys 22,148 Shares of Novo Nordisk A/S $NVO

Saratoga Research & Investment Management Sells 200,320 Shares of Novo Nordisk A/S $NVO

Merit Financial Group LLC Has $53.25 Million Stock Position in Johnson & Johnson $JNJ

Johnson & Johnson $JNJ Stock Holdings Decreased by Gateway Investment Advisers LLC

Monument Capital Management Decreases Stake in Gilead Sciences, Inc. $GILD

Monument Capital Management significantly reduced its stake in Gilead Sciences by 56.1% in the second quarter, selling over 15,000 shares. Despite this, institutional investors collectively own 83.67% of the company, and analysts maintain a "Moderate Buy" consensus with an average price target of $158.04. …

Mirae Asset Global Investments Co. Ltd. Increases Stake in Novo Nordisk A/S $NVO

Bernstein Adjusts PT on Regeneron Pharmaceuticals to $756 From $753, Maintains Market Perform Rating

Bernstein has increased its price target for Regeneron Pharmaceuticals (REGN) to $756 from $753, while maintaining a "Market Perform" rating on the stock. This adjustment reflects a modest change in the analyst's valuation, indicating a continued neutral stance on the company's stock performance. The …

17,243 Shares in Johnson & Johnson $JNJ Bought by Thomasville National Bank

Rallybio Corp (RLYB) sees Balyasny group report 0% ownership in 13G/A

MiNK Therapeutics (NASDAQ:INKT) Stock Rating Lowered by Zacks Research

QV Investors Inc. Acquires 81,870 Shares of Novo Nordisk A/S $NVO

Johnson & Johnson $JNJ Shares Bought by Interchange Capital Partners LLC

Bristol Myers Squibb announces new $2.3bn campus in the US

Bristol Myers Squibb has announced a new $2.3 billion multi-modal manufacturing campus in Houston, Texas, creating nearly 500 skilled jobs. This investment is part of BMS's $40 billion commitment to the US, aiming to accelerate the delivery of next-generation medicines. The campus's modular design …

Centene (CNC) Stock Still Looks Like A Bargain As Shares Jumped 145%

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Centene stock has surged over the past year, yet the current checks still suggest it leans on the cheap side, so investors are weighing how …

Eton Pharmaceuticals jumps on strong Q2 print, 2026 guidance

Shares in Eton Pharmaceuticals (ETON [https://seekingalpha.com/symbol/ETON]) rallied 25% in premarket trading on Friday, driven by a solid quarterly print and 2026 revenue forecast, which the company said would exceed $145M while targeting adjusted EBITDA margin above 35%. Chief executive officer Sean Brynjelsen said the …

Confluence Wealth Services Inc. Acquires 7,986 Shares of Gilead Sciences, Inc. $GILD

Confluence Wealth Services Inc. significantly increased its stake in Gilead Sciences, Inc. (NASDAQ:GILD) by 251.4% during the second quarter, acquiring an additional 7,986 shares, bringing its total holdings to 11,162 shares valued at $1.41 million. Gilead reported strong Q2 revenue of $7.80 billion, exceeding …

Brown Shipley& Co Ltd Acquires New Shares in Thermo Fisher Scientific Inc. $TMO

Brown Shipley & Co Ltd has acquired 10,509 shares of Thermo Fisher Scientific Inc. (NYSE:TMO) valued at approximately $5.27 million, making it their 11th largest holding. Thermo Fisher Scientific recently reported strong quarterly earnings, exceeding analyst estimates with an EPS of $6.03 and revenue …

Exchange Traded Concepts LLC Cuts Stock Holdings in Novo Nordisk A/S $NVO

Stock index futures largely flat after S&P 500 closes at record high

[Wall Street New York stock exchange stock market] alexsl Stock index futures were muted on Friday after the S&P 500 closed at a record high in the previous session. Dow futures (INDU [https://seekingalpha.com/symbol/INDU]) -0.12%, S&P 500 futures (SPX [https://seekingalpha.com/symbol/SPX]) +0.02%, and Nasdaq futures (US100:IND) …

Gilead Sciences, Inc. $GILD Stock Position Lifted by Exchange Traded Concepts LLC

Dimensional Fund Advisors LP Has $1.85 Million Stock Holdings in Tempus AI, Inc. $TEM

Assenagon Asset Management S.A. Acquires 4,334 Shares of Quest Diagnostics Incorporated $DGX

Assenagon Asset Management S.A. increased its stake in Quest Diagnostics Incorporated by 39.1% in the second quarter, acquiring 4,334 shares and bringing its total holdings to 15,405 shares valued at approximately $3.27 million. The medical research company reported strong Q2 earnings, exceeding estimates with …

Dimensional Fund Advisors LP Sells 288,067 Shares of Summit Therapeutics PLC $SMMT

Dimensional Fund Advisors LP significantly reduced its stake in Summit Therapeutics PLC by 76.5% in the first quarter, selling over 288,000 shares. Despite this, Summit Therapeutics has seen strong insider buying, with executives acquiring 7.87 million shares worth approximately $103.6 million in the past …

Dimensional Fund Advisors LP Sells 12,867 Shares of Rhythm Pharmaceuticals, Inc. $RYTM

Dimensional Fund Advisors LP reduced its stake in Rhythm Pharmaceuticals, Inc. by 40.2% in the first quarter, selling 12,867 shares and retaining 19,151 shares valued at approximately $1.67 million. Despite the sale, Rhythm Pharmaceuticals reported strong quarterly revenue growth of 46.9% year-over-year and beat …

How Investors Are Reacting To Rhythm Pharmaceuticals (RYTM) UK Orphan Expansion For IMCIVREE In Hypothalamic Obesity

Rhythm Pharmaceuticals received expanded UK MHRA authorization and orphan drug designation for IMCIVREE to treat hypothalamic obesity, broadening its market in the UK. While this strengthens the rare-disease thesis for the drug, the company continues to operate at a significant loss, underscoring ongoing funding …

Thermo Fisher Scientific and KYAN Technologies Sign MoU to Advance Functional Precision Oncology for Solid Tumours

Thermo Fisher Scientific and KYAN Technologies have signed an MoU to advance functional precision oncology for solid tumours. The collaboration will use patient-derived tumoroid models, functional drug-response screening, and genomic analysis to gather patient-relevant data across various cancers, aiming to improve therapeutic decision-making. They …

DaVita (DVA) Stock Looks Discounted On Earnings While Returns Look Strong

Bank of America Corp DE Decreases Position in Edgewise Therapeutics, Inc. $EWTX

Smith & Nephew SNATS, Inc. $SNN Shares Sold by Bank of America Corp DE

Bank of America Corp DE reduced its stake in Smith & Nephew SNATS, Inc. (NYSE:SNN) by 12.5% in the first quarter, selling 176,622 shares but still retaining over 1.2 million shares valued at approximately $39.4 million. Despite this sale, several other institutional investors increased …

Arcus Biosciences, Inc. Stock 12‑Month Price Target Raised to $38.82, Implies 35% Upside

Arcus Biosciences, Inc. (RCUS) has seen its average 12-month price target raised from $38.33 to $38.82 by 11 analysts, with forecasts ranging from $23 to $47 per share. This new target implies a potential upside of approximately 35% from its August 13 closing price. …

5 Insightful Analyst Questions From Cencora’s Q2 Earnings Call

5 Insightful Analyst Questions From Cencora's Q2 Earnings Call Cencora's second quarter was marked by performance that met Wall Street's expectations on revenue and exceeded consensus on non-GAAP profitability, driving a positive market response. Management credited execution in specialty pharmaceuticals, especially through its Management …

Envetec Appoints Patrick S. Jones as Independent Director

Envetec Senior Thermo Fisher Scientific executive brings nearly 30 years of healthcare and commercial leadership to support Envetec's global expansion Patrick S. JonesPatrick S. Jones, President of Thermo Fisher Scientific's Clinical Diagnostics Division and independent director of Envetec Sustainable Technologies BIRDHILL, Ireland, Aug. 14, …

Why Is Becton Dickinson (BDX) Getting Fresh Attention Today?

Becton Dickinson (BDX) is gaining attention after completing enrollment in its PREVENT clinical trial for Phasix Mesh, a significant step towards future U.S. regulatory submission. The stock has seen strong short-term gains, up over 20% in the last 30 days, raising questions about whether …

HSBC Bank Plc Reports No Stabilisation in National Grid North America Inc's EUR 1.3 Billion Dual-Tranche Euro Bond Issue

HSBC Bank plc has confirmed that no stabilization activities were conducted for National Grid North America Inc's EUR 1.3 billion dual-tranche euro-denominated bond issue. The bond offering includes EUR 700 million at 3.643% notes due April 2031 and EUR 600 million at 4.268% notes …

5 Insightful Analyst Questions From Charles River Laboratories’s Q2 Earnings Call

5 Insightful Analyst Questions From Charles River Laboratories's Q2 Earnings Call Charles River Laboratories' second quarter results were shaped by recovering biopharmaceutical demand and the impact of portfolio streamlining. Management highlighted that the rebound was most evident in the Discovery and Safety Assessment (DSA) …

5 Revealing Analyst Questions From Eli Lilly’s Q2 Earnings Call

5 Revealing Analyst Questions From Eli Lilly's Q2 Earnings Call Eli Lilly's second quarter was marked by a positive market reaction, despite the company missing Wall Street's revenue expectations. Management credited growth in key products—especially in cardiometabolic health, oncology, and neuroscience—as drivers of performance. …